BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,551,798 | -5.2% | 30,900 | +19.3% | 0.02% | -6.2% |
| Q2 2023 | $1,636,880 | +54.8% | 25,900 | +10.2% | 0.02% | +45.5% |
| Q1 2023 | $1,057,265 | +10.2% | 23,500 | +7.3% | 0.01% | +10.0% |
| Q4 2022 | $959,439 | -14.3% | 21,900 | +28.8% | 0.01% | -23.1% |
| Q3 2022 | $1,120,130 | +11.0% | 17,000 | +7.6% | 0.01% | +44.4% |
| Q1 2022 | $1,009,000 | -38.0% | 15,800 | +3.9% | 0.01% | -18.2% |
| Q4 2021 | $1,628,000 | -40.5% | 15,200 | -42.9% | 0.01% | -60.7% |
| Q3 2021 | $2,735,000 | -1.3% | 26,600 | -15.6% | 0.03% | +3.7% |
| Q2 2021 | $2,771,000 | +8.4% | 31,500 | +19.8% | 0.03% | +8.0% |
| Q1 2021 | $2,557,000 | +37.3% | 26,300 | +58.4% | 0.02% | +25.0% |
| Q4 2020 | $1,862,000 | +58.2% | 16,600 | +30.7% | 0.02% | +53.8% |
| Q3 2020 | $1,177,000 | +201.8% | 12,700 | +154.0% | 0.01% | +160.0% |
| Q2 2020 | $390,000 | -45.9% | 5,000 | -44.4% | 0.01% | -37.5% |
| Q4 2019 | $721,000 | – | 9,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |